1. Home
  2. TCPC vs GNFT Comparison

TCPC vs GNFT Comparison

Compare TCPC & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCPC
  • GNFT
  • Stock Information
  • Founded
  • TCPC 2006
  • GNFT 1999
  • Country
  • TCPC United States
  • GNFT France
  • Employees
  • TCPC N/A
  • GNFT N/A
  • Industry
  • TCPC Finance/Investors Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TCPC Finance
  • GNFT Health Care
  • Exchange
  • TCPC Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • TCPC 648.0M
  • GNFT 209.2M
  • IPO Year
  • TCPC 2012
  • GNFT 2019
  • Fundamental
  • Price
  • TCPC $7.84
  • GNFT $4.51
  • Analyst Decision
  • TCPC Hold
  • GNFT Strong Buy
  • Analyst Count
  • TCPC 4
  • GNFT 1
  • Target Price
  • TCPC $7.50
  • GNFT $13.00
  • AVG Volume (30 Days)
  • TCPC 597.2K
  • GNFT 10.0K
  • Earning Date
  • TCPC 05-08-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • TCPC 17.35%
  • GNFT N/A
  • EPS Growth
  • TCPC N/A
  • GNFT N/A
  • EPS
  • TCPC N/A
  • GNFT 0.03
  • Revenue
  • TCPC $259,596,996.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • TCPC N/A
  • GNFT $15.98
  • Revenue Next Year
  • TCPC N/A
  • GNFT N/A
  • P/E Ratio
  • TCPC N/A
  • GNFT $145.64
  • Revenue Growth
  • TCPC 20.88
  • GNFT 105.01
  • 52 Week Low
  • TCPC $6.27
  • GNFT $2.55
  • 52 Week High
  • TCPC $11.52
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • TCPC 62.34
  • GNFT 63.33
  • Support Level
  • TCPC $7.79
  • GNFT $4.22
  • Resistance Level
  • TCPC $7.89
  • GNFT $4.39
  • Average True Range (ATR)
  • TCPC 0.17
  • GNFT 0.21
  • MACD
  • TCPC 0.04
  • GNFT -0.00
  • Stochastic Oscillator
  • TCPC 91.38
  • GNFT 93.09

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: